Literature DB >> 8388027

Absence of nonpercutaneous transmission of hepatitis C virus in a colony of chimpanzees.

E Suzuki1, S Kaneko, T Udono, T Tanoue, Y Hayashi, N Yoshihara, S Murakami, N Hattori, M Hayashi, S Sasaoka.   

Abstract

Transmission of hepatitis C virus (HCV) was studied in a colony of 85 chimpanzees using assays for anti-HCV and HCV-RNA. Thirteen of the 85 sera were positive for anti-HCV, and 12 of the 13 were also positive for HCV-RNA. All of the anti-HCV positive sera except one were obtained from chimpanzees which had been inoculated with non-A, non-B hepatitis virus. On the other hand, only one of 63 sera of chimpanzees without history of experimental infection of the virus was positive for anti-HCV. Transmission to this chimpanzee was thought to be a needle contaminated with HCV. All 39 samples of chimpanzees born in the center were negative for both anti-HCV and HCV-RNA. Sixteen of their mothers had undergone experimental infection, and 6 of them were positive for both anti-HCV and HCV-RNA. These results suggest that nonpercutaneous transmission, including sexual and mother-to-infant transmissions, is not an important mode of transmission. If these findings apply to humans, definition of inapparent sources of the infection is needed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388027     DOI: 10.1002/jmv.1890390406

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  [Detection and significance of HCV RNA in saliva, seminal fluid and vaginal discharge in patients with hepatitis C].

Authors:  Z Tang; D Yang; L Hao; Z Tang; Y Huang; S Wang
Journal:  J Tongji Med Univ       Date:  1996

Review 2.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

3.  Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles.

Authors:  S E Bassett; K M Brasky; R E Lanford
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.